ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO703

Long-Term Kidney Outcomes in Pediatric Renal Vein Thrombosis

Session Information

  • Pediatric Nephrology - 1
    October 25, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Pediatric Nephrology

  • 1900 Pediatric Nephrology

Authors

  • Oseguera, Mayra A., Nationwide Children's Hospital, Columbus, Ohio, United States
  • Khalid, Myda, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Kerlin, Bryce A., Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States
Background

Pediatric renal vein thrombosis (RVT) may increase the long-term risk for adverse renal outcomes. Most literature focuses on neonatal RVT, with low emphasis on long-term renal outcomes. There is sparse data on renal outcomes following RVT in older children. The goal of this project is to determine long-term renal outcomes of RVT across the pediatric age spectrum.

Methods

The PHIS (Pediatric Health Information System) database was used to identify patients from birth to 21 years of age with a diagnosis of RVT. We looked for the occurrence and persistence of hypertension, proteinuria, and eGFR reduction. Secondary outcomes analyzed were end stage renal disease and mortality.

Results

We identified 516 children with a diagnosis of RV in the PHIS database (Table 1). 51.9% were male. The mean age for RVT diagnosis was 2.6 years, the most common age at diagnosis was in the neonates. Children as old as 17 years of age were also identified. 20% of the affected individuals had residual CKD. Residual HTN occurred in 30.6% of the patients. (Table 1).

Conclusion

Pediatric RVT is a risk factor for the development of CKD and hypertension regardless of age at RVT diagnosis. Survivors of pediatric RVT should be routinely screened for evolving CKD and/or hypertension. We plan a deeper analysis of these data to determine if anticoagulant therapy alters long-term renal outcomes following pediatric RVT.

CharacteristicN (%)
Unique patients516
Male sex268 (51.9)
Age at RVT, years2.6 (0.01-11.1)
Renal complex chronic condition flag (before or after RVT)319 (61.8)
Mortality66 (12.8)
Renal Outcomes190 (36.8)
AKI106 (20.5)
CKD103 (20.0)
Kidney failure3 (0.6)
Atrophy of kidney13 (2.5)
Small kidney5 (1.0)
Infarction of the kidney21 (4.1)
Dialysis dependent26 (5.0)
HTN158 (30.6)
Proteinuria15 (2.9)

Table 1